{
  "docId": "019dd923-622c-750b-8b9a-2a2468219173",
  "docSlug": "ce565b841c40",
  "documentTitle": "Nevro Corp. (NVRO)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Kir Kahlon",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-01-07 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 146,
  "pageCount": 239,
  "prevPage": 145,
  "nextPage": 147,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": "Uses yellow highlighting to emphasize key claims of deception.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "bullet_list",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-2a2468219173/146",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-146",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "Nevro, in our opinion, has pushed a fraudulent narrative that Omnia represents a new technology or product strategy.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b343-fcbaf396eb88",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.88,
        "x": 0.06,
        "y": 0.33
      },
      "kind": "list",
      "text": "KOL’s stated that Omnia isn’t “anything new,” that the devices “could always do low frequency,” and that Nevro already offered this capability to doctors, especially those with high explant rates from high frequency.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "561b8415-e29d-4a14-9813-a04521d00a0a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.88,
        "x": 0.06,
        "y": 0.13
      },
      "kind": "paragraph",
      "text": "Interestingly, former employees and KOL’s stated that Omnia isn’t even a new offering: Nevro’s previous stimulators already included the capability to offer low-frequency stimulation, which the company downplayed for fear that it would undermine its claims of high frequency’s supposed efficacy. Multiple interviews indicated that Nevro’s HQ and field reps long offered it to KOL’s who soured on high-frequency. Nevro, in our opinion, has pushed a fraudulent narrative that Omnia represents a new technology or product strategy. If shipping low-frequency with previous devices failed to prevent Nevro’s sales crash, we wonder why it would be the company’s savior now.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bf4394dd-c334-4a1f-aafa-50ea283c4eae",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.88,
        "x": 0.06,
        "y": 0.71
      },
      "kind": "quote",
      "text": "“Even a few years before Omnia came out, Nevro was allowing doctors in certain segments of the country to shift their devices to low frequency. Nevro didn’t advertise it. But if you had a high explant rate or were deemed an important person, they would fly out one of their head engineers and say \"Listen, because you’re you, we’re going to let you do tonic [low frequency stimulation] for the patients that are failing.” – KOL",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1803be28-43f8-4241-b348-f8893eeeb32c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.88,
        "x": 0.06,
        "y": 0.57
      },
      "kind": "quote",
      "text": "“Nevro’s device could always do low frequency, but they put restrictors on it because they didn’t want the reps doing that. Nevro knew what was always going to happen: a person fails high frequency and it’s natural to put them back into low frequency stimulation. Nevro didn’t do anything new [with Omnia]. They just used a new case and rebranded it without the restrictor.” – KOL",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "24188fe3-ad8a-4b6c-9d58-91e986e38ae0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.88,
        "x": 0.06,
        "y": 0.43
      },
      "kind": "quote",
      "text": "“If you speak to reps from other stim companies, they’ll tell you that Senza had all of that capability in there and just never used it. I met with [a key Nevro engineer] a few weeks ago to have him explain to me what’s in the guts of the Omnia and he admitted to me that a lot of its capabilities were there in the previous device but they never marketed it.” – KOL and former high volume Nevro implanter",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "621ac989-0270-400a-9e65-d4f11e7ef6d0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "If you speak to reps from other stim companies, they’ll tell you that Senza had all of that capability in there and just never used it. I met with [a key Nevro engineer] a few weeks ago to have him explain to me what’s in the guts of the Omnia and he admitted to me that a lot of its capabilities were there in the previous device but they never marketed it. — KOL and former high volume Nevro implanter",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-3f3d-76db-b344-03cb8034577a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.2,
        "x": 0.06,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: Consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a132e898-c733-4919-b6a4-7fcdc8e29782",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.88,
        "x": 0.06,
        "y": 0.09
      },
      "kind": "title",
      "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c5d94cc3-b157-4c4b-b255-c985d7692b21",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.4,
        "x": 0.06,
        "y": 0.04
      },
      "kind": "title",
      "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "36c1940f-ef55-4c2a-92f2-397f2d85edaa",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "e77e3001-9043-418f-bbbd-b1b7c86f8f56",
      "evidence": "The slide explicitly claims a 'fraudulent narrative' regarding product innovation.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 150,
      "from": 51,
      "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Victory",
      "beatSlug": "overcoming-monster-the-victory",
      "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}